[go: up one dir, main page]

FI46505C - Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones. - Google Patents

Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones.

Info

Publication number
FI46505C
FI46505C FI692843A FI284369A FI46505C FI 46505 C FI46505 C FI 46505C FI 692843 A FI692843 A FI 692843A FI 284369 A FI284369 A FI 284369A FI 46505 C FI46505 C FI 46505C
Authority
FI
Finland
Prior art keywords
9alpha
6alpha
16alpha
11beta
pregnadiene
Prior art date
Application number
FI692843A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI46505B (en
Inventor
Kerb
Kolb
Klink
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19681801390 external-priority patent/DE1801390C3/en
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of FI46505B publication Critical patent/FI46505B/en
Publication of FI46505C publication Critical patent/FI46505C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI692843A 1968-10-02 1969-10-02 Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones. FI46505C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681801390 DE1801390C3 (en) 1968-10-02 6,9,21-trihalo steroids, processes for their preparation, medicaments containing them and 6,21-dihalo intermediates

Publications (2)

Publication Number Publication Date
FI46505B FI46505B (en) 1973-01-02
FI46505C true FI46505C (en) 1973-04-10

Family

ID=5709719

Family Applications (1)

Application Number Title Priority Date Filing Date
FI692843A FI46505C (en) 1968-10-02 1969-10-02 Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones.

Country Status (16)

Country Link
AT (1) AT290033B (en)
BE (1) BE739736A (en)
BR (1) BR6912959D0 (en)
CH (1) CH540891A (en)
CS (1) CS150285B2 (en)
DK (1) DK121053B (en)
ES (1) ES372061A1 (en)
FI (1) FI46505C (en)
FR (1) FR2019676A1 (en)
GB (1) GB1286659A (en)
IE (1) IE33329B1 (en)
IL (1) IL33017A (en)
NL (1) NL167439C (en)
NO (1) NO130824C (en)
RO (1) RO54664A (en)
SE (1) SE352082B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (en) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen New 21-Halogen Steroids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series

Also Published As

Publication number Publication date
IL33017A (en) 1974-01-14
NO130824C (en) 1975-02-19
BR6912959D0 (en) 1973-02-08
CH540891A (en) 1973-08-31
AT290033B (en) 1971-05-10
IL33017A0 (en) 1969-11-30
RO54664A (en) 1973-03-15
ES372061A1 (en) 1971-09-01
FR2019676A1 (en) 1970-07-03
NL167439C (en) 1981-12-16
IE33329B1 (en) 1974-05-29
IE33329L (en) 1970-04-02
DE1801390B2 (en) 1977-02-17
DK121053B (en) 1971-08-30
BE739736A (en) 1970-04-02
DE1801390A1 (en) 1970-05-21
NL6914942A (en) 1970-04-06
SE352082B (en) 1972-12-18
NL167439B (en) 1981-07-16
NO130824B (en) 1974-11-11
FI46505B (en) 1973-01-02
GB1286659A (en) 1972-08-23
CS150285B2 (en) 1973-09-04

Similar Documents

Publication Publication Date Title
NO1994013I1 (en) Budenoside / 16¿, 17¿-alkylenedioxypregna-1,4-diene-3,20-diones
FI49035C (en) Process for the preparation of therapeutically useful 2-bromo-alpha-gocryptine.
FI44906C (en) Analogue method for the treatment of therapeutically active 11beta, 21-dihydroxy-3,20-diones or 21-hydroxy-3,11,20-trione-pregna-1,4-diene- (17alpha, 16alpha-d) -2'-methyloxazolines or their For the preparation of 21-esters i
DK139031B (en) Analogous process for the preparation of alkylated 3,20-dioxo-delta4 steroids of the pregnane series in the 21-position.
DK128352B (en) Analogous process for the preparation of 9α-fluoro-11β-hydroxypregna-1,4-diene-3,20-dione- [17α, 16α-d] -oxazolidinoxazines.
DK120190B (en) Analogous process for the preparation of therapeutically active 17-esters of 9α, 11β-dihalo-16α-alkyl-Δ <1,4> -pregnadiene-17α, 21-diol-3,20-diones.
DK131474B (en) Analogous process for the preparation of 9alpha-halogen-11beta, 17alpha, 21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-21-adamantane-1'-carboxylates.
DK134816B (en) Analogous process for the preparation of esters of 11beta, 17alpha, 21-trihydroxy-16beta-methylpregna-1,4,8-triene-3,20-dione.
DK133382B (en) Analogous process for the preparation of 6alpha, 9alpha-difluor-11beta, 17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-diacetate.
FI46505C (en) Process for the preparation of therapeutically useful 6alpha, 9alpha, 2-trihalogen-16alpha-methyl-11beta-hydroxy-1,4-pregnadiene-3,20-diones.
FI46844C (en) Process for the preparation of 9alpha, 21,21-trichlorosteroids.
DK114060B (en) Process for the preparation of therapeutically effective 1,2β-methylene steroids of the androstane or 9-norandrostane series.
FI47092C (en) Process for the preparation of therapeutically valuable mixture-substituted 1-phenoxy-3-alkylaminopropanols- (2).
FI47358C (en) Process for the preparation of therapeutically useful 4'-demethyl-epi podophyllotoxin-beta-D-glucoside.
DK132121B (en) Process for the preparation of 17alpha-hydroxypregna-4,9 (11) -diene-3,20-dione.
FI46952C (en) Process for the preparation of 6alpha-fluoro-9alpha, 11beta, 21-trihalogen-1,4-pregnadiene-3,20-dione derivatives
FI47350C (en) Process for the preparation of 17alpha-propadienyl steroids.
ZA717774B (en) New 6alpha-fluoro-16alpha,18-dimethyl-delta 1,4-pregnadiene-3,20-diones
DK126937B (en) Process for the preparation of 4,6-dihalo-16-alkylidene-17α-hydroxy-pregna-4,6-diene-3,20-diones.
FI49159C (en) Process for the preparation of 9alpha-halogen-6alpha, 16alpha-dimethyl-1,4 -pregnadiene-3,20-dione derivatives.
FI47573C (en) Process for the preparation of -fluoro-11,21-dihydroxy-16,17 (2-propenylidenedioxy) -p Regna-1,4-diene-3,20-dione and its 21-esters.
AU4145272A (en) 6alpha,9alpha-difluorosteroids of the pregnane series
FI47181C (en) Process for the preparation of anti-inflammatory 2-chloro-6alpha, 9alpha, 11beta-trihalogen-16alpha-methyl-pregnadiene.
FI47483C (en) Process for the preparation of 6alpha-fluoro-9alpha-21-dihalo-11beta-hydroxy-16-methyl-1,4-pregnadiene 3,20-diones
DK113640B (en) Analogous process for the preparation of therapeutically active 9α, 11β-dihalogen-pregna-1,4-diene- [17α, 16α-d] -oxazoline-3,20-diones.